Medicine Man Technologies, Inc. to Present at the Rodman & Renshaw 21st Annual Global Investment Conference
DENVER, Sept. 5, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or "Company"), today announced that it will be presenting at the Rodman & Renshaw 21st Annual Global Investment Conference, to be held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City.
Mr. Joe Puglise, Chief Operating Officer of Medicine Man Technologies, will deliver a corporate presentation and discuss the Company's recent highlights on Monday, September 9, 2019 at 4:40 PM ET. Mr. Puglise will also be available for one-on-one meetings during the conference.
For more information about Medicine Man Technologies, please visit https://www.medicinemantechnologies.com/.
About Medicine Man Technologies
Denver, Colorado-based Medicine Man Technologies (MDCL) is a rapidly growing provider of cannabis consulting services, nutrients and supplies. The Company's client portfolio includes active and past clients in 20 states and 7 countries throughout the cannabis industry. The Company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry. Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products internationally. The Company's intellectual property includes the "Three A Light" methodology for cannabis cultivation and pending acquisition candidate MedPharm's GMP-certified facility, which has the first cannabis research license to conduct clinical trials in the United States. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives.
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services; (ii) our ability to complete and integrate acquisitions; (iii) general industry and economic conditions; and (iv) our ability to access adequate financing on terms and conditions that are acceptable to us, as well as other risks identified in our filings with the SEC. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Investor Relations Contact:
View original content to download multimedia:http://www.prnewswire.com/news-releases/medicine-man-technologies-inc-to-present-at-the-rodman--renshaw-21st-annual-global-investment-conference-300912200.html
SOURCE Medicine Man Technologies, Inc.
Released September 5, 2019